BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 10767176)

  • 1. Carrier assessment in families with lowe oculocerebrorenal syndrome: novel mutations in the OCRL1 gene and correlation of direct DNA diagnosis with ocular examination.
    Röschinger W; Muntau AC; Rudolph G; Roscher AA; Kammerer S
    Mol Genet Metab; 2000 Mar; 69(3):213-22. PubMed ID: 10767176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of OCRL1 mutations in two Taiwanese Lowe syndrome patients.
    Chou YY; Chao SC; Chiou YY; Lin SJ
    Acta Paediatr Taiwan; 2005; 46(4):226-9. PubMed ID: 16381338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel OCRL1 mutation in a patient with the mild phenotype of Lowe syndrome.
    Sugimoto K; Nishi H; Miyazawa T; Fujita S; Okada M; Takemura T
    Tohoku J Exp Med; 2014 Mar; 232(3):163-6. PubMed ID: 24614960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of mutations in the OCRL1 gene in the Lowe oculocerebrorenal syndrome.
    Lin T; Orrison BM; Leahey AM; Suchy SF; Bernard DJ; Lewis RA; Nussbaum RL
    Am J Hum Genet; 1997 Jun; 60(6):1384-8. PubMed ID: 9199559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations are not uniformly distributed throughout the OCRL1 gene in Lowe syndrome patients.
    Lin T; Orrison BM; Suchy SF; Lewis RA; Nussbaum RL
    Mol Genet Metab; 1998 May; 64(1):58-61. PubMed ID: 9682219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a germline mosaicism in families with Lowe syndrome, and identification of seven novel mutations in the OCRL1 gene.
    Satre V; Monnier N; Berthoin F; Ayuso C; Joannard A; Jouk PS; Lopez-Pajares I; Megabarne A; Philippe HJ; Plauchu H; Torres ML; Lunardi J
    Am J Hum Genet; 1999 Jul; 65(1):68-76. PubMed ID: 10364518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oculocerebrorenal syndrome of Lowe: three mutations in the OCRL1 gene derived from three patients with different phenotypes.
    Kawano T; Indo Y; Nakazato H; Shimadzu M; Matsuda I
    Am J Med Genet; 1998 Jun; 77(5):348-55. PubMed ID: 9632163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of two novel mutations in the OCRL1 gene in Japanese families with Lowe syndrome.
    Kubota T; Sakurai A; Arakawa K; Shimazu M; Wakui K; Furihata K; Fukushima Y
    Clin Genet; 1998 Sep; 54(3):199-202. PubMed ID: 9788721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OCRL1 mutation analysis in French Lowe syndrome patients: implications for molecular diagnosis strategy and genetic counseling.
    Monnier N; Satre V; Lerouge E; Berthoin F; Lunardi J
    Hum Mutat; 2000; 16(2):157-65. PubMed ID: 10923037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel interstitial deletion in Xq25, identified by array-CGH in a patient with Lowe syndrome.
    Addis M; Meloni C; Congiu R; Santaniello S; Emma F; Zuffardi O; Ciccone R; Cao A; Melis MA; Cau M
    Eur J Med Genet; 2007; 50(1):79-84. PubMed ID: 17142121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular Pathology of Oculocerebrorenal Syndrome of Lowe: Novel Mutations and Genotype-Phenotype Analysis.
    Song E; Luo N; Alvarado JA; Lim M; Walnuss C; Neely D; Spandau D; Ghaffarieh A; Sun Y
    Sci Rep; 2017 May; 7(1):1442. PubMed ID: 28473699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in OCRL1 gene in Indian children with Lowe syndrome.
    Sethi SK; Bagga A; Gulati A; Hari P; Gupta N; Lunardi J
    Clin Exp Nephrol; 2008 Oct; 12(5):358-362. PubMed ID: 18500547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical mapping and genomic structure of the Lowe syndrome gene OCRL1.
    Nussbaum RL; Orrison BM; Jänne PA; Charnas L; Chinault AC
    Hum Genet; 1997 Feb; 99(2):145-50. PubMed ID: 9048911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional overlap between murine Inpp5b and Ocrl1 may explain why deficiency of the murine ortholog for OCRL1 does not cause Lowe syndrome in mice.
    Jänne PA; Suchy SF; Bernard D; MacDonald M; Crawley J; Grinberg A; Wynshaw-Boris A; Westphal H; Nussbaum RL
    J Clin Invest; 1998 May; 101(10):2042-53. PubMed ID: 9593760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular confirmation of carriers for Lowe syndrome.
    Lin T; Lewis RA; Nussbaum RL
    Ophthalmology; 1999 Jan; 106(1):119-22. PubMed ID: 9917791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OCRL mutation analysis in Italian patients with Lowe syndrome.
    Addis M; Loi M; Lepiani C; Cau M; Melis MA
    Hum Mutat; 2004 May; 23(5):524-5. PubMed ID: 15108291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel and de novo deletion in the OCRL1 gene associated with a severe form of Lowe syndrome.
    Peces R; Peces C; de Sousa E; Vega C; Selgas R; Nevado J
    Int Urol Nephrol; 2013 Dec; 45(6):1767-71. PubMed ID: 22821049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel OCRL1 gene mutation in a Turkish child with Lowe syndrome.
    Kanık A; Kasap-Demir B; Ateşli R; Eliaçık K; Yavaşcan O; Helvacı M
    Turk J Pediatr; 2013; 55(1):82-5. PubMed ID: 23692838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of two novel mutations in the OCRL1 gene in two Chinese families with Lowe syndrome.
    Ke YH; He JW; Fu WZ; Zhang ZL
    Nephrology (Carlton); 2012 Jan; 17(1):20-5. PubMed ID: 21854507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of missense mutations in the RhoGAP-homology domain on ocrl1 function.
    Lichter-Konecki U; Farber LW; Cronin JS; Suchy SF; Nussbaum RL
    Mol Genet Metab; 2006; 89(1-2):121-8. PubMed ID: 16777452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.